Is systemic inflammation the main driver of skeletal muscle weakness during COPD exacerbations (AE)?

T. Troosters, F. Pitta, V. Probst, G. Celis, M. Spruit, R. Gosselink, M. Decramer (Leuven, Belgium)

Source: Annual Congress 2005 - Physiotherapy techniques: from evaluation to rehabilitation
Session: Physiotherapy techniques: from evaluation to rehabilitation
Session type: Thematic Poster Session
Number: 1166
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Troosters, F. Pitta, V. Probst, G. Celis, M. Spruit, R. Gosselink, M. Decramer (Leuven, Belgium). Is systemic inflammation the main driver of skeletal muscle weakness during COPD exacerbations (AE)?. Eur Respir J 2005; 26: Suppl. 49, 1166

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006


Distribution of leg muscle weakness in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Assessing profiles of rehabilitation candidates
Year: 2008



The effect of COPD on muscle structure and function
Source: Annual Congress 2006 - COPD: a systemic disease affecting the muscles
Year: 2006


Cardiac muscle mass and function are associated with altered body composition in patients with COPD
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007


The relationship between proximal limb and trunk muscle strength and respiratory parameters in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015

Correlation between respiratory muscles function, systemic inflammation and dyspnoea in patients with severe COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Vitamin D receptor genotypes influence quadriceps strength in COPD
Source: Annual Congress 2007 - Pathophysiology of respiratory muscles
Year: 2007


Influence of reduced airway patency and respiratory muscle strength on autonomic cardiac modulation in COPD patients
Source: International Congress 2016 – Quality and quantity in lung function
Year: 2016

Ubiquitin expression is up-regulated in peripheral muscle in elderly patients with COPD
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006


The impact of systemic corticosteroids on respiratory muscle function in severe asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 505s
Year: 2005

Handgrip strength reflects excersice capacity and systemic inflammation in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Risk of severe exacerbations in COPD patients associates with mass of intercostal and abdominal muscles: a CT scan study
Source: Annual Congress 2006 - Respiratory muscles
Year: 2006


Resistance versus endurance training in patients with COPD and peripheral muscle weakness
Source: Eur Respir J 2002; 19: 1072-1078
Year: 2002



Respiratory and skeletal muscles in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=201
Year: 2006

Non-invasive monitoring of emphysema and muscle wasting during experimental disease exacerbation
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study
Source: Eur Respir J 2011; 38: 781-788
Year: 2011



Strategies of muscle training in very severe COPD patients
Source: Eur Respir J 2011; 38: 971-975
Year: 2011



Corticosteroids affect skeletal muscle strength in mild level of breathlessness of patients with interstitial lung disease
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020